Distal Bile Duct Cancer Overview

Distal bile duct cancer is an uncommon form of cholangiocarcinoma that develops in the lower portion of the bile duct outside the liver, near the pancreas and small intestine. Distal tumors are a subtype of extrahepatic bile duct cancer.

In the United States, bile duct cancers overall account for approximately 8,000 diagnoses each year. Because distal tumors are typically grouped with other bile duct cancers in national reporting, they are not always tracked separately. Still, some estimates suggest that about 40% of cholangiocarcinomas arise in the distal bile duct.

What are the types of distal bile duct cancer?

Distal bile duct cancer is classified based on the appearance of the tumor cells when viewed under a microscope. The most common type is adenocarcinoma, in which the cells often form irregular gland-like structures and produce mucus, reflecting their origin in the bile duct lining. A pathology report may also describe less common variants, such as papillary tumors, which grow in fingerlike projections into the bile duct. These cells may have an enlarged, dark-staining nucleus, an abnormal shape and a disorganized growth pattern.

Pathologists also assess how closely the tumor cells resemble healthy bile duct cells. Well-differentiated tumors tend to look more like normal glandular tissue and may grow more slowly, while poorly differentiated tumors appear more abnormal, with fewer recognizable gland structures and a higher likelihood of aggressive behavior. The report may also note other important features, such as invasion into nearby tissues and spread into blood vessels or lymphatic channels, which can help guide treatment decisions.

What causes distal bile duct cancer?

Scientists believe distal bile duct cancer arises when bile duct cells acquire harmful DNA changes over time, causing the cells to grow uncontrollably and form tumors. Some of these changes are associated with chronic inflammation or injury to the bile ducts. In many cases, however, there is no single identifiable cause.

What are the risk factors for distal bile duct cancer?

Risk factors for distal bile duct cancer include conditions that cause long-term bile duct inflammation or obstruction, such as:

• Bile duct stones – Hardened bile deposits can block the duct, causing repeated injury and inflammation.
• Choledochal cysts and other bile duct abnormalities – Congenital or structural abnormalities of the bile ducts can disrupt normal bile flow and promote chronic irritation of the duct lining.
• Liver disease or viral hepatitis – Long-standing liver inflammation from a chronic condition, such as hepatitis B or C or cirrhosis, may contribute to bile duct damage and increase cancer risk in some individuals.
• Liver flukes – More common in parts of Asia, parasitic infections caused by organisms such as Clonorchis sinensis and Opisthorchis species can lead to long-term bile duct inflammation and significantly increase the risk of bile duct cancer.
• Primary sclerosing cholangitis (PSC) – A chronic condition that causes scarring and narrowing of the bile ducts, PSC can cause ongoing inflammation and an increased risk of bile duct cancer over time.
• Recurrent bile duct inflammation – Repeated episodes of cholangitis or bile duct irritation can damage bile duct cells and increase the likelihood of cancer-related changes.

Is distal bile duct cancer preventable?

There is no known way to completely prevent distal bile duct cancer. However, the risk may be reduced by addressing modifiable contributors when possible, such as:

• Treating underlying liver disease and viral hepatitis
• Avoiding tobacco use
• Following medical guidance for bile duct disorders, including PSC and choledochal cysts
• Seeking a medical evaluation for persistent jaundice or an abnormal liver test result

For a patient with a high-risk bile duct condition, the healthcare team may recommend structured surveillance based on the patient’s health history.

What are the signs and symptoms of distal bile duct cancer?

The symptoms of distal bile duct cancer are often related to a blockage of bile flow, which can cause bile to back up into the bloodstream.

What are the early warning signs of distal bile duct cancer?

Early symptoms can be subtle. Sometimes, the first sign of distal bile duct cancer is:

• Dark urine
• Pale or greasy stools
• Skin itching
• Unexplained fatigue
• Yellowing of the skin or eyes (jaundice)

What are common symptoms of distal bile duct cancer?

Other frequently reported symptoms of distal bile duct cancer include:

• Abdominal discomfort, often in the upper right quadrant
• Loss of appetite
• Nausea
• Unintentional weight loss

What are the signs of advanced distal bile duct cancer?

As the tumor progresses or causes more systemic effects, the symptoms may become more severe, such as:

• Persistent abdominal pain
• More pronounced digestive symptoms due to ongoing bile obstruction
• Noticeable weight loss
• Recurrent infections of the bile duct (cholangitis), sometimes with fever and chills
• Worsening weakness

What are the signs that distal bile duct cancer has spread?

The symptoms of metastatic distal bile duct cancer can vary based on the organs and tissues affected. Possible signs include:

• Bone pain – Can occur if the cancer weakens the bones, which may cause localized or persistent pain
• Increasing abdominal swelling – Often caused by fluid buildup in the abdomen (ascites), which can occur if the cancer affects the liver or the lining of the abdominal cavity
• Declining appetite – May result from liver involvement, digestive system disruption or the body’s overall response to advanced cancer
• New or worsening pain – Can occur if the cancer spreads to organs, nerves or soft tissues near the bile duct, such as the liver and abdominal structures
• Progressive fatigue – Often reflects the body’s systemic response to advanced cancer and may be related to anemia, liver dysfunction or widespread disease
• Shortness of breath – May develop if the cancer metastasizes to the lungs or if fluid accumulates around the lungs, limiting normal breathing

How is distal bile duct cancer diagnosed?

Typically, the diagnostic process for distal bile duct cancer combines a medical history review, lab work, imaging studies and tissue sampling. Because bile duct tumors can be difficult to classify, this evaluation often focuses on confirming:

• Whether there is a bile duct blockage and, if so, where it is located
• Whether cancer is present and, if so, whether it has spread beyond the bile duct

What laboratory tests are used to diagnose distal bile duct cancer?

Common lab tests used to diagnose distal bile duct cancer include:

• Basic metabolic panel (BMP) – BMP evaluates overall body function by measuring electrolytes, kidney function and blood glucose. The results can help guide medication and treatment planning.
• Complete blood count (CBC) – CBC measures the levels of red blood cells, white blood cells and platelets, which can help identify anemia, infection or inflammation and establish a baseline before treatment.
• Liver function tests – Bilirubin and alkaline phosphatase levels may become elevated if a bile duct blockage is present, while liver enzymes such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST) may rise if the liver is irritated or inflamed.
• Tumor markers tests – Carbohydrate antigen (CA) 19-9 and sometimes carcinoembryonic antigen (CEA) levels may be elevated in bile duct cancer. While not diagnostic on its own, tumor marker testing can support the overall evaluation and may be used to monitor the patient’s response to treatment over time.

What imaging tests are used to diagnose distal bile duct cancer?

Medical images may reveal a bile duct obstruction, tumor or possible cancer spread. Common imaging tests used to diagnose distal bile duct cancer include:

• Abdominal ultrasound – Often the first imaging test used when jaundice is present, ultrasound can detect bile duct dilation, blocked bile flow, gallstones and masses.
• Computed tomography (CT) scan – CT can provide detailed cross-sectional images of the abdomen, which can help the physician identify the location and size of a tumor and evaluate nearby organs and lymph nodes. This information can support staging and surgical planning.
• Magnetic resonance imaging (MRI) with magnetic resonance cholangiopancreatography (MRCP) – MRI with MRCP offers high-resolution images of the bile ducts and surrounding soft tissues without radiation exposure. MRCP can be especially useful for showing the exact site and extent of a bile duct obstruction.
• Positron emission tomography (PET) scan – Often combined with CT for enhanced accuracy, PET may be used in select cases to check for areas of cancer spread by highlighting tissues with increased metabolic activity.

Top 1% of Cancer Hospitals

Listed among U.S. News & World Report's Best Cancer Hospitals as one of the top-ranked high-performing cancer hospitals in the nation.

Schedule an Appointment

What procedures are used to diagnose distal bile duct cancer?

A procedure may be performed to confirm the diagnosis, obtain tissue samples or, in some cases, relieve bile duct obstruction. Options may include:

• Cholangioscopy – This procedure uses a small camera passed through an endoscope, allowing the physician to directly visualize the interior of the bile ducts, identify abnormal areas and perform targeted biopsies in select cases.
• Diagnostic laparoscopy – This minimally invasive surgical procedure uses small incisions and a miniature camera to help the physician examine the abdomen. It is sometimes performed before major surgery to check for cancer spread that may not be visible on imaging studies.
• Endoscopic retrograde cholangiopancreatography (ERCP) – ERCP uses an endoscope and contrast dye to help the physician visualize the bile ducts. During the procedure, the physician may take brushings or biopsies to collect cell samples or place a stent to open a blocked bile duct and relieve jaundice.
• Endoscopic ultrasound (EUS) with needle biopsy – EUS combines endoscopy with ultrasound imaging to help the physician closely examine the bile duct, pancreas and nearby lymph nodes. The physician may use a fine needle to obtain tissue samples from suspicious areas with heightened accuracy.

How is distal bile duct cancer treated?

Treatment for distal bile duct cancer can vary depending on the location and stage of the tumor and whether surgery is possible. Care is typically planned by a multispecialty team and may include a combination of surgery, systemic therapy and radiation therapy.

How is surgery used to treat distal bile duct cancer?

If the tumor is localized and the patient is healthy enough to safely undergo an operation, surgery may offer the best chance for long-term cancer control. The most common procedure for distal bile duct cancer is a pancreaticoduodenectomy, also known as a Whipple procedure, which removes the distal bile duct along with some nearby structures and lymph nodes.

If surgical treatment is not immediately possible, a procedure such as biliary stenting may be considered to relieve jaundice and improve liver function before other therapies.

How is chemotherapy used to treat distal bile duct cancer?

Chemotherapy is a systemic treatment that uses powerful medications to destroy cancer cells or slow their growth. The drugs may be delivered intravenously or taken by mouth, depending on the specific treatment plan. For distal bile duct cancer, chemotherapy may be administered:

• Before surgery – In select cases, chemotherapy may be used to shrink the tumor and improve the likelihood of successful surgical removal. It can also be used to determine how the cancer responds to treatment.
• After surgery – Chemotherapy is often used to help reduce the risk of recurrence by targeting microscopic cancer cells that may remain after the tumor has been removed. For resected biliary tract cancers, clinical guidelines support the use of capecitabine after initial treatment.
• For an unresectable tumor – If surgery is not an option, chemotherapy may be used to slow tumor growth or relieve symptoms.
• For metastatic cancer – A common first-line chemotherapy approach for advanced biliary tract cancer is gemcitabine plus cisplatin. The addition of durvalumab is approved by the FDA for locally advanced or metastatic cancer.

The healthcare team may also recommend molecular profiling of the tumor to look for actionable biomarkers and guide targeted therapy or immunotherapy options when appropriate.

How is radiation therapy used to treat distal bile duct cancer?

Radiation therapy is a localized treatment that uses high-energy beams to destroy cancer cells or prevent them from growing and dividing. The treatment is carefully planned and targeted to minimize exposure to the surrounding healthy tissues. For distal bile duct cancer, radiation therapy may be used:

• After surgery – In select cases, radiation therapy may be combined with chemotherapy to help lower the risk of recurrence, especially when cancer cells are found close to the surgical margins or in nearby lymph nodes.
• For locally advanced cancer – If the cancer cannot be completely removed with surgery, radiation therapy may be considered to help control tumor growth.
• For symptom relief – Radiation therapy may help ease pain and other symptoms caused by advanced cancer, improving the patient’s comfort and quality of life.

Benefit from world-class care at Moffitt Cancer Center

Moffitt offers comprehensive care for patients with distal bile duct cancer, including a robust portfolio of clinical trials. As a National Cancer Institute (NCI)-designated Comprehensive Cancer Center, we have earned national recognition for our extensive research efforts and scientific leadership.

If you would like to learn more about distal bile duct cancer, you can request an appointment with a specialist in the Gastrointestinal Oncology Program at Moffitt by calling 1-888-663-3488 or submitting a new patient registration form online. We do not require referrals.